Premium
Xenon Pharmaceuticals Inc (XENE)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Dr. Gary PatouIndependent Director | -1,32k | 70,25k | Automatic Disposition | 53,14 | 29,80k | -4,25% |
| 2026-06-05 | Dr. Gillian M. CannonIndependent Director | -1,19k | 63,24k | Automatic Disposition | 53,14 | 1,46k | -44,99% |
| 2026-06-01 | Mr. Justin D. GoverIndependent Director | 2,65k | 0,00 | Derivative Exercise and Retained Stock | - | 2,65k | - |
| 2026-06-01 | Dr. Gary PatouIndependent Director | 2,65k | 0,00 | Derivative Exercise and Retained Stock | - | 31,12k | 9,29% |
| 2026-06-01 | Mr. C. Patrick MachadoIndependent Director | 2,65k | 0,00 | Derivative Exercise and Retained Stock | - | 2,65k | - |
| 2026-06-01 | Dr. Elizabeth A. GarofaloIndependent Director | 2,65k | 0,00 | Derivative Exercise and Retained Stock | - | 2,65k | - |
| 2026-06-01 | Mr. Steven R. GannonIndependent Director | -1,42k | 75,63k | Derivative Exercise and Sale | 53,41 | 11,87k | - |
| 2026-06-01 | Mr. Steven R. GannonIndependent Director | 1,23k | 0,00 | Derivative Exercise and Retained Stock | - | 11,87k | 11,55% |
| 2026-06-01 | Dr. Gillian M. CannonIndependent Director | 2,65k | 0,00 | Derivative Exercise and Retained Stock | - | 2,65k | - |
| 2026-06-01 | Ms. Dawn A. SvoronosIndependent Chairman | -1,42k | 75,63k | Derivative Exercise and Sale | 53,41 | 26,23k | - |
| 2026-06-01 | Ms. Dawn A. SvoronosIndependent Chairman | 1,23k | 0,00 | Derivative Exercise and Retained Stock | - | 26,23k | 4,92% |
| 2026-05-12 | Mr. Steven R. GannonIndependent Director | 3,50k | 25,83k | Derivative Exercise and Retained Stock | 7,38 | 10,64k | 49,01% |
| 2026-03-12 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | 2,41k | 0,00 | Derivative Exercise and Retained Stock | - | 7,30k | 49,21% |
| 2026-03-12 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | -1,34k | 74,11k | Derivative Exercise and Sale | 55,23 | 7,30k | - |
| 2026-03-12 | Dr. Christopher John KenneyChief Medical Officer | 2,34k | 0,00 | Derivative Exercise and Retained Stock | - | 7,07k | 49,48% |
| 2026-03-12 | Dr. Christopher John KenneyChief Medical Officer | -1,41k | 77,87k | Derivative Exercise and Sale | 55,23 | 7,07k | - |
| 2026-03-12 | Mr. Ian C. MortimerPresident, CEO & Director | 5,19k | 0,00 | Derivative Exercise and Retained Stock | - | 34,22k | 17,88% |
| 2026-03-12 | Mr. Ian C. MortimerPresident, CEO & Director | -7,31k | 403,58k | Derivative Exercise and Sale | 55,23 | 34,22k | - |
| 2026-03-09 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | 4,89k | 0,00 | Derivative Exercise and Retained Stock | - | 4,89k | - |
| 2026-03-09 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | -2,61k | 156,70k | Derivative Exercise and Sale | 60,11 | 4,89k | - |
| 2026-03-09 | Dr. Christopher John KenneyChief Medical Officer | 4,73k | 0,00 | Derivative Exercise and Retained Stock | - | 4,73k | - |
| 2026-03-09 | Dr. Christopher John KenneyChief Medical Officer | -2,77k | 166,56k | Derivative Exercise and Sale | 60,11 | 4,73k | - |
| 2026-03-09 | Mr. Ian C. MortimerPresident, CEO & Director | 20,00k | 0,00 | Derivative Exercise and Retained Stock | - | 29,03k | 221,46% |
| 2026-03-09 | Mr. Ian C. MortimerPresident, CEO & Director | -270,00k | 14,47M | Derivative Exercise and Sale | 3,10 - 62,06 | 29,03k | - |
| 2026-03-10 | Mr. Ian C. MortimerPresident, CEO & Director | -11,27k | 677,36k | Automatic Disposition | 60,11 | 29,03k | -27,96% |
| 2026-01-02 | Mr. Ian C. MortimerPresident, CEO & Director | -40,00k | 1,48M | Derivative Exercise and Sale | 7,49 - 44,93 | 20,30k | - |
| 2025-12-05 | Mr. Ian C. MortimerPresident, CEO & Director | -25,21k | 1,14M | Automatic Disposition | 45,03 - 46,32 | 20,30k | -55,39% |
| 2025-11-28 | Mr. Ian C. MortimerPresident, CEO & Director | -97,00 | 4,37k | Automatic Disposition | 45,01 | 45,51k | -0,21% |
| 2025-10-15 | Mr. Thomas Patrick KellyCFO | 225,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 29,87 | 225,00k | - |
| 2025-10-15 | Mr. Thomas Patrick KellyCFO | 30,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 30,00k | - |
| 2025-10-01 | Mr. Ian C. MortimerPresident, CEO & Director | -25,00k | 1,00M | Vente | 40,16 | 45,60k | -35,41% |
| 2025-10-01 | Mr. Ian C. MortimerPresident, CEO & Director | 25,00k | 192,25k | Derivative Exercise and Retained Stock | 7,69 | 45,60k | 121,35% |
| 2025-10-01 | Mr. Ian C. MortimerPresident, CEO & Director | -25,00k | 811,75k | Derivative Exercise and Sale | 7,69 - 40,16 | 45,60k | - |
| 2025-06-23 | Mr. Darren S. ClineChief Commercial Officer | 185,80k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 22,93 | 185,80k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
